By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zafgen 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: 617-236-0535 Fax: 617-249-0490


SEARCH JOBS



Segment
Start Up





Company News
Zafgen (ZFGN) Initiates Multiple Ascending Dose Cohorts In Phase I Clinical Trial Of ZGN-1061 9/20/2016 7:55:35 AM
Zafgen (ZFGN) Reports Second Quarter 2016 Financial Results 8/5/2016 8:46:02 AM
Zafgen (ZFGN) To Present At Canaccord Genuity’s 36th Annual Growth Conference 8/4/2016 8:19:19 AM
Zafgen (ZFGN) Pinks Slips 34% of Workforce, Scraps Lead Obesity Drug After Deaths 7/20/2016 6:19:16 AM
Zafgen (ZFGN)'s Alicia Secor Steps Up as Juniper Pharma (JNP)’s President and CEO 7/20/2016 5:42:21 AM
Zafgen (ZFGN) Presents New Data From The Phase IIb Clinical Trial Evaluating Beloranib In Severe Obesity Complicated By Type 2 Diabetes At The American Diabetes Association's 76th Scientific Sessions 6/13/2016 7:48:46 AM
10 Massachusetts Biotechs Devoting the Most Cash to R&D 5/5/2016 6:29:13 AM
Zafgen (ZFGN) To Host Conference Call To Discuss First Quarter 2016 Financial Results 5/4/2016 7:55:30 AM
Zafgen (ZFGN) Presents New Data From The Phase III Bestpws Study Evaluating Beloranib In Prader-Willi Syndrome At ENDO 2016 4/4/2016 7:34:49 AM
Zafgen (ZFGN) To Present Data From Bestpws Study Of Beloranib In Prader-Willi Syndrome At ENDO 2016 3/29/2016 8:07:35 AM
12345678910...
//-->